Skip to main content
LEAP THERAPEUTICS, INC. logo

LEAP THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LPTX ISIN · US52187K2006 LEI · 549300T31SMMJ2DDLI13 US Manufacturing
Filings indexed 584 across all filing types
Latest filing 2017-11-29 Regulatory Filings
Country US United States of America
Listing US LPTX

About LEAP THERAPEUTICS, INC.

https://www.leaptx.com/

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer. Its most advanced clinical candidate, DKN-01 (sirexatamab), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, being developed for patients with esophagogastric, gynecologic, and colorectal cancers. The company's pipeline also includes FL-301, a monoclonal antibody targeting Claudin18.2 for gastric and pancreatic cancer, and FL-501, a preclinical antibody targeting the growth and differentiation factor 15 (GDF-15) protein.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2017
Regulatory Filings
2017-11-29 English
SC 13G
Major Shareholding Notification
2017-11-22 English
SC 13D
Major Shareholding Notification
2017-11-21 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement financing transaction where the company issued shares and warrants to investors, including details about the purchase agreements, placement agents, and use of proceeds. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document focuses on a capital raising event and related agreements. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length is over 10,000 characters, indicating it is a full report rather than a brief announcement or certification.
2017-11-17 English
PRIMARY DOCUMENT
Director's Dealing
2017-11-16 English
4
Director's Dealing
2017-11-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.